Cefixime and Leukopenia - a phase IV clinical study of FDA data

Summary:

Leukopenia is reported as a side effect among people who take Cefixime (cefixime), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Fycompa, and have Epilepsy.

The phase IV clinical study analyzes which people have Leukopenia when taking Cefixime. It is created by eHealthMe based on reports of 3,217 people who have side effects when taking Cefixime from the FDA, and is updated regularly.

What is Cefixime?

Cefixime has active ingredients of cefixime. eHealthMe is studying from 3,237 Cefixime users. Check the latest studies of Cefixime.

What is Leukopenia?

Leukopenia (less number of white blood cells in blood) is found to be associated with 1,702 drugs and 2,287 conditions by eHealthMe. Check the latest studies of Leukopenia.

On Apr, 22, 2026

3,217 people reported to have side effects when taking Cefixime.
Among them, 15 people (0.47%) have Leukopenia.

Among these 15 people:

How long have people been on Cefixime when they have Leukopenia? *

What is the gender of people who have Leukopenia when taking Cefixime? *

female: 53.85 %
male: 46.15 %

What is the age of people who have Leukopenia when taking Cefixime? *

What are other drugs people take besides Cefixime? *

What are other side effects people have besides Leukopenia? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 46.67%
Anaemia (lack of blood): 4 people, 26.67%
Fever: 4 people, 26.67%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 20.00%
Thrombocytopenia (decrease of platelets in blood): 3 people, 20.00%
Bone Pain: 3 people, 20.00%
Lymphopenia (an abnormally low level of lymphocytes in the blood): 2 people, 13.33%
Pleural Effusion (water on the lungs): 2 people, 13.33%
Weakness: 2 people, 13.33%
Nausea (feeling of having an urge to vomit): 2 people, 13.33%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 20.00%
Tonsillitis (inflammation of tonsil): 1 person, 6.67%
Skin Papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections): 1 person, 6.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 6.67%
Ewing's Sarcoma (malignant small, round, blue cell tumour): 1 person, 6.67%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 1 person, 6.67%
High Blood Cholesterol: 1 person, 6.67%
Hypersensitivity: 1 person, 6.67%
Kidney Infection (Pyelonephritis): 1 person, 6.67%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cefixime and have Leukopenia?

- Check whether Leukopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefixime:

Cefixime (3,237 reports)

Leukopenia treatments and more:

Leukopenia (58,665 reports)

Browse all side effects of Cefixime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Leukopenia:

Leukopenia (1,702 drugs)

Browse all the conditions that are associated with Leukopenia:

Leukopenia (2,287 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefixime (the active ingredients of Cefixime) and Cefixime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.